Navigation Links
Two-Drug Combo Helps Teens With Migraines
Date:5/15/2012

By Amanda Gardner
HealthDay Reporter

TUESDAY, May 15 (HealthDay News) -- A two-drug combination that relieves migraines in adults also works well in adolescents, new research indicates.

Although the findings basically support what doctors are already doing, "it is nice to have this officially shown in a study in adolescents," said Dr. Ellen Drexler, associate director of neurology at Maimonides Medical Center in New York City.

Because the combination of Imitrex (sumatriptan) and naproxen sodium (Aleve and other brand names) isn't approved for use by the U.S. Food and Drug Administration for this age group, doctors must prescribe it "off label" to adolescents.

"There are no FDA-approved abortive [migraine] treatments for children," said Dr. Noah Rosen, director of the Headache Center at the Cushing Neuroscience Institute in Great Neck, N.Y. "This is the first really large-scale abortive treatment study for adolescents."

The study, funded and carried out by researchers at GlaxoSmithKline, which makes the sumatriptan/naproxen combined tablet, known as Treximet, appears in the May 14 issue of Pediatrics.

Migraines in children and adolescents are physiologically no different from migraines in adults, said Drexler, although migraines in younger people tend not to last as long.

Although treatments are similar to those used in adults, not many trials have formally tested their effectiveness in children and adolescents.

The class of drugs known as triptans are the most studied, but none of those trials have shown a great benefit, possibly because of a large placebo response, the study authors wrote.

Some 8 percent to 23 percent of children aged 11 and older experience migraines, the researchers stated.

For this study, the authors randomly assigned almost 600 teens and preteens -- 12 to 17 years old -- to either a placebo or one of three doses of the sumatriptan/naproxen combination over a period of 12 weeks.

The doses were 10 milligrams (mg) sumatriptan and 60 mg naproxen, 30/180 mg and 85/500 mg, respectively.

Between 23 percent and 29 percent of those who took one of the doses of sumatriptan/naproxen reported being pain-free within two hours of taking the drug, vs. 10 percent in the placebo group.

"This is a significant amount of people to be pain-free," said Rosen.

The 85/500 mg version of the drug showed greater benefit when taking into account pain relief and sensitivity to light and sound. Nausea rates, however, were no better than in the placebo group.

Participants receiving one of the other two doses of the drug combination had lower rates of nausea.

Rosen said that most previous studies looked at pain reduction only.

Side effects were minimal and the same in all groups.

The authors did state that the 10/60 mg combination may be the best choice for lower-weight adolescents with shorter-duration migraines, given that it was effective and reduced nausea.

Treximet was approved by the FDA for use in adults in 2008. It's unclear if GlaxoSmithKline will apply for a pediatric indication for the drug from the agency.

More information

The Cleveland Clinic has more on migraines in children and adolescents.

SOURCES: Ellen Drexler, M.D., associate director, neurology, Maimonides Medical Center, New York City; Noah Rosen, M.D., director, Headache Center, Cushing Neuroscience Institute, Great Neck, N.Y.; May 14, 2012, Pediatrics


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Late-stage ovarian cancer shows promise in two-drug phase I trial
2. Elderly Lung Cancer Patients Can Gain From Two-Drug Chemo: Study
3. Short-Term Drug Combo May Help Prevent Colon Cancer
4. Bone Marrow Cancer Patients May Benefit From Drug Combo
5. Drug Combo Staves Off Type 2 Diabetes
6. Binge Drinking, Hypertension a Deadly Combo
7. Exercise Combo Best for Type 2 Diabetes
8. New combo lung cancer therapy improves survival over single-line treatment
9. In Women, Diabetes Plus Depression a Deadly Combo
10. Risks May Outweigh Benefits for Blood Pressure Drug Combo
11. Diet-Exercise Combo Seems to Work Best for Obese Seniors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Two-Drug Combo Helps Teens With Migraines
(Date:5/27/2016)... ... May 27, 2016 , ... An educational campaign ... inspiring human-interest stories, courtesy of awareness-driven celebrities and thought leaders. It also provides ... associations and industry leaders such as Bioness. , As patients feel increasingly ...
(Date:5/27/2016)... ... 2016 , ... Aimed at nurses and employees in the health care world, ... in the nursing and health care industry. It also provides insight to the developing ... , As the nursing industry is coming out of one of the biggest ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... There are ... Hot Dog and Sausage Council (NHDSC) suggests that Americans prefer their dogs straight off ... 63 percent say grilling is their favorite way to cook a hot dog, far ...
(Date:5/26/2016)... ... 2016 , ... Georgia State University College of Law is ... Answering to the increasing demand for curricular specializations, the Certificate in Intellectual Property ... land use law. ,  , “The demand for lawyers with specific knowledge in ...
(Date:5/26/2016)... ... 2016 , ... Cardiac arrhythmia is a common complication following ... survival, reports a team of UPMC researchers in the largest study of its ... Thoracic and Cardiovascular Surgery, provide critical information that will hopefully lead to better ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... -- The healthcare sector is large and ... falling under its umbrella.  A rather overlooked sector are ... about, these healthcare companies are still trying to prove ... by far the largest consumer of the healthcare market ... Nutranomics Inc. (OTC: NNRX), KollagenX Corp. (OTCQB: KGNX), Bioelectronics ...
(Date:5/26/2016)... -- TARE (Transarterial Radio-embolization) Using Yttrium-90 ... Overall Decreased Use of Hospital Resource ... healthcare company, has today announced the publication of ... ISPOR (International Society for Pharmacoeconomics and Outcomes Research), ... yttrium-90 glass microspheres is associated with cost savings ...
(Date:5/25/2016)... 25,2016 FDA 510(k) clearance ... platform for urological and surgical applications ... of Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) ... the US with the 12 th 510(k) ... (FDA). This new FDA clearance covers Confocal Miniprobes ...
Breaking Medicine Technology: